All Stories

  1. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia

    Article • Scandinavian Journal of Gastroenterology, September 2019, Taylor & Francis

    Jens F. Rehfeld

  2. Fructose malabsorption triggers CCK release through fructose metabolism by gut microbiota

    Article • The FASEB Journal, April 2019, Federation of American Societies For Experimental Biology (FASEB)

    veronique douard, Dr Philippe Gérard, Jens F. Rehfeld

  3. Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy

    Article • Clinical Medicine Insights Endocrinology and Diabetes, January 2019, SAGE Publications

    Jens F. Rehfeld

  4. Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

    Article • Scandinavian Journal of Gastroenterology, November 2018, Taylor & Francis

    Jens F. Rehfeld, prof Jens Juul Holst

  5. Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels

    Article • Journal of Nutrition and Metabolism, January 2018, Hindawi Publishing Corporation

    Jens F. Rehfeld, prof Jens Juul Holst

  6. The long goodbye to glycine-extended peptide hormones

    Article • International Journal of Endocrine Oncology, November 2017, Future Medicine

    Jens F. Rehfeld

  7. Single-Dose Metformin Enhances Bile Acid–Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2017, Endocrine Society

    Dr Filip K Knop, Jens F. Rehfeld, prof Jens Juul Holst

  8. CCK, gastrin and diabetes mellitus

    Article • Biomarkers in Medicine, November 2016, Future Medicine

    Jens F. Rehfeld